EUVIMEDEUVIMED entdecken
Open Access

Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy

Erika Ciervo iD, Francesco Ceccarelli iD, Anna Maria Di Giacomo iD, Piera Grisolia iD, Alessia Covre iD, Zein Mersini Besharat iD, Antonio De Falco iD, Francesca Pia Caruso iD, Luigi Laezza iD, Luigi Ferraro iD, Gloria Mas Martin iD, Daniel Bilbao iD und 13 weitere

Science Advances · 07.08.2026 · 12 (32)

DOI: 10.1126/sciadv.aed1318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 07.08.2026. Verfasst von Erika Ciervo und 24 weiteren Autor:innen. Beteiligte Einrichtung: Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA. Hauptthemen laut MEDLINE: Melanoma, Epigenesis, Genetic, Immunotherapy, DNA Transposable Elements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Associazione Italiana per la Ricerca sul Cancro, National Cancer Institute Cancer Center Support Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma plasticity drives immune evasion and therapy resistance through dynamic cell-state transitions beyond genetic alterations. Although epigenetic remodeling is central to this process, its impact under therapeutic pressure remains unclear. We profiled longitudinal biopsies from patients with melanoma treated in the phase 1b NIBIT-M4 epi-immunotherapy trial [NCT02608437, DNA (cytosine-5)-methyltransferase 1 inhibitor plus anti–CTLA-4] using single-cell multiome and spatial transcriptomics. Seven malignant meta-programs were identified, including a rare Wnt/β-Catenin melanocytic state and a dedifferentiated neural crest–like state enriched in nonresponders. Spatial analyses showed that homotypic clustering stabilizes resistant programs, with neural crest–like cells forming compact niches. Responders displayed enrichment of antigen presentation/interferon program and coordinated T and B cell expansion, whereas nonresponders retained stable neural crest–like clusters. Epigenetic therapy reactivated transposable elements, priming innate immunity and enhancing immunogenicity. Nuclear factor of activated T cells, cytoplasmic 2 (NFATC2) emerged as a master regulator of neural crest–like states and resistance; its perturbation promoted differentiation and immunogenicity. These findings define mechanisms of resistance and nominate β-Catenin and NFATC2 as therapeutic vulnerabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaEpigenesis, GeneticImmunotherapyDNA Transposable ElementsDrug Resistance, NeoplasmHumansbeta CateninNFATC Transcription FactorsGene Expression Regulation, NeoplasticTumor Microenvironment

Substanzen

DNA Transposable Elementsbeta CateninNFATC Transcription Factors

Autor:innen und Institutionen

  • Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Biogem Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.
  • Department of Computer Science and Technology, University of Cambridge, Cambridge, UK.
  • University of Siena, Italy, and Center for Immuno-Oncology, Department of Oncology, University Hospital of Siena, Siena, Italy.
  • NIBIT Foundation Onlus, Siena, Italy.
  • Department of Experimental Medicine, Sapienza University, Rome, Italy.

ORCID-Profile: Erika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo, Piera Grisolia, Alessia Covre, Zein Mersini Besharat, Antonio De Falco, Francesca Pia Caruso, Luigi Laezza, Luigi Ferraro, Gloria Mas Martin, Daniel Bilbao, Sion Williams, Benjamin Currall, Maria Fortunata Lofiego, Elisabetta Ferretti, Yan Guo, Sean B Holden, Roberta Mortarini, Andrea Anichini, Michele Maio, Teresa Maria Rosaria Noviello, Michele Ceccarelli

Förderung

  • NCI NIH HHS
  • Associazione Italiana per la Ricerca sul Cancro
  • National Cancer Institute Cancer Center Support Grant
  • National Center for Gene Therapy and Drugs
  • European Union -Next Generation EU
  • NIBIT Foundation Onlus

Zitieren

APA

Ciervo, E., Ceccarelli, F., Di Giacomo, A. M., Grisolia, P., Covre, A., Besharat, Z. M., De Falco, A., Caruso, F. P., Laezza, L., Ferraro, L., Martin, G. M., Bilbao, D., Williams, S., Currall, B., Lofiego, M. F., Sani, T., Ferretti, E., Guo, Y., Holden, S. B., …, & Ceccarelli, M. (2026). Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aed1318

Vancouver

Ciervo E, Ceccarelli F, Di Giacomo AM, Grisolia P, Covre A, Besharat ZM, et al. Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy. Science Advances. 2026;12(32). doi:10.1126/sciadv.aed1318

BibTeX
@article{Ciervo2026,
  author = {Ciervo, Erika and Ceccarelli, Francesco and Di Giacomo, Anna Maria and Grisolia, Piera and Covre, Alessia and Besharat, Zein Mersini and De Falco, Antonio and Caruso, Francesca Pia and Laezza, Luigi and Ferraro, Luigi and Martin, Gloria Mas and Bilbao, Daniel and Williams, Sion and Currall, Benjamin and Lofiego, Maria Fortunata and Sani, Tommaso and Ferretti, Elisabetta and Guo, Yan and Holden, Sean B and Simeone, Ines and Mortarini, Roberta and Anichini, Andrea and Maio, Michele and Noviello, Teresa Maria Rosaria and Ceccarelli, Michele},
  title = {Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {32},
  doi = {10.1126/sciadv.aed1318}
}
Kostenlos starten →